GSE110368
p53 ChIP-seq in PHA-stimulated human T-lymphocytes
ChIP-seq profiles of p53 binding in PHA-stimulated human T-lymphocytes treated with either Doxorubicin, Nutlin-3, or DMSO Overall design: Individual ChIP-seq profiles of p53 binding in PHA-stimulated human T-lymphocytes (from four healthy volunteers) treated ex vivo with either Doxorubicin, Nutlin-3, or DMSO. Input sequences were used as controls.